Prenatal screening for chromosome abnormalities

British Medical Bulletin

Volumn 54, Issue 4, 1998, Pages 839-856

  Chitty, Lyn ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANEUPLOIDY; CHROMOSOME ABERRATION; COST BENEFIT ANALYSIS; FETUS; FETUS WASTAGE; HUMAN; MATERNAL SERUM; PRENATAL SCREENING; PRIORITY JOURNAL; REVIEW; STILLBIRTH;

EID: 0032406033     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011733     Document Type: Review

References (22)

1. Hook EB. Chromosome abnormalities: prevalence, risks and recurrence. In: Brock DJH, Rodeck CH, Ferguson-Smith MA. (eds) Prenatal Diagnosis and Screening. Edinburgh: Churchill Livingstone, 1998; 351-92
2. Palomaki GE, Neveux LM, Haddow JE. Can reliable Down's syndrome detection rates be determined from prenatal screening intervention trials? J Med Screen 1996; 3: 12-7
3. Hook EB, Cross PK, Regal RR. The frequency of 47,+21,47,+18, and 47,+13 at the uppermost extremes of maternal ages: results on 56,094 fetuses studied prenatally and comparisons with data on livebirths. Hum Genet 1984; 28: 211-20
4. Ferguson-Smith MA, Yates JRW. Maternal age specific rates for chromosomal aberrations factors influencing them: report of a collaborative European study on 52,965 amniocenteses. Prenat Diagti 1984; 4: 5-14
5. Macintosh MCM, Wald NJ, Chard T et al. The selective miscarriage of Down's syndrome from 10 weeks of pregnancy. Br J Obstet Gynaecol 1996; 103: 1171-2
6. Snijders RJM, Sebire NJ, Nicolaides KH. Maternal age and gestational age-specific rates for chromosomal defects. Fetal Diagn Ther 1995; 10: 349-55
7. Mutton D, Ide RG, Alberman ED. Trends in prenatal screening diagnosis of Down's Syndrome: England and Wales 1989-97. BMJ 1998; 317: 922-3
8. O'Leary P, Bower C, Murch A, Crowhurst J, Goldblart J. The impact of antenatal screening for Down syndrome in Western Australia: 1980-1994. Amt NZJ Obstet Gynaecol 1996; 36: 385-8
9. Chitty LS, Barnes CA, Berry C. Continuing with pregnancy after a diagnosis of lethal abnormality: experience of five couples and recommendations for management. BMJ 1996; 313:478-80
10. Chitty LS, Chudleigh P, Wright E, Campbell S, Pembrey ME. The significance of choroid plexus cysts in an unselected population: the results of a multicentre study. Ultrasound Obstet Gynecol 1998; 12: 1-7
11. Huang T, Watt HC, Wald NJ. The effect of differences in the distribution of maternal age in England and Wales on the performance of prenatal screening for Down's syndrome. Prenat Diagn 1997; 17: 615-21
12. Wald NJ, Kennard A, Hackshaw A, McGuire A. Antenatal screening for Down's syndrome. J Med Screen 1997; 4: 181-246
13. Hackshaw AK, Kennard A, Wald NJ. Detection of pregnancies with trisomy 18 in screening for Down's syndrome, J Med Screen 1995; 2: 228-9
14. Palomaki GE, Haddow JE, Knight GJ et al. Risk-based screening for trisomy 18 using alphafetoprotein, unconjugated oestriol and human chorionic gonadotrophin. Prenat Diagn 1995; 15: 713-23
15. Goldstein H, Nielson ICG. Rates and survival in individuals with trisomy 13 and 18. Clin Genet 1988; 27: 59-61
16. Carter PE, Pearn JH, Bell J, Martin W, Anderson NG. Survival in trisomy 18. Life tables for use in genetic counselling and clinical paediatrics, Clin Genet 1985; 17: 59-61
17. Barkai G, Goldman B, Ries L, Chaki R, Zer T, Cuckle H. Expanding multiple marker screening for Down's syndrome to include Edward's syndrome. Prenat Diagn 1993; 13: 843-50
18. Cuckle HS, Holding S, Jones R, Groome NP, Wallace EM. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome. Prenat Diagn 1996; 16: 1095-100
19. Spencer K, Wallace EM, Ritoe S. Second-trimester dimeric inhibin-A in Down's syndrome screening. Prenat Diagn 1996; 16: 1101-10
20. Wald NJ, Densem JW, George L et al. Inhibin-A in Down's syndrome pregnancies: revised estimate of standard deviation. Prenat Diagn 1997; 17: 285-90
21. Wald NJ, George L, Smith D, Densem JW, Petterson K. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. Br J Obstet Gynaecol 1996; 103: 407-12
22. Spencer K, Aitken DA, Macri JN, Buchannan PD. Urine free beta hCG and beta core in pregnancies affected by-Down syndrome. Prenat Diagn 1996; 16: 605-13